Clinical Trial Update: Biomarker Exploration in Aging, Cognition and Neurodegeneration [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update exploring biomarkers in aging, cognition and neurodegeneration for Alzheimer’s disease and related cognitive conditions; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Decline
• Cognitive Impairment

Snippet

Sponsor: University of California, Irvine | Conditions: Alzheimer Disease, Cognitive Impairment | Phase 3 | Status: RECRUITING